Revive Therapeutics Ltd (RVVTF)

[Snoop_dog]

I am confident that bucillamine holds great promise in combatting COVID. However, I do have some reservations about the CEO's ability to deliver on this potential. I am optimistic that the efficacy data will be positive, paving the way for the global distribution of bucillamine to every single person on Earth.

What You Need to Know
There is strong scientific evidence that antiviral treatment of outpatients at risk for severe COVID-19 reduces their risk of hospitalization and death.
The antiviral drugs nirmatrelvir with ritonavir (Paxlovid) , remdesivir (Veklury) and {? Bucillamine?} are the preferred treatments for eligible adult and pediatric patients who are at high risk for progression to severe COVID-19.
Clinicians should consider COVID-19 treatment in patients with mild-to-moderate COVID-19 who have one or more risk factors for severe COVID-19. Treatment must be started early to be effective.


https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/outpatient-treatment-overview.html